Wrong, they have limited resources, and must allocate them appropriately depending upon the circumstances, and conferences are not critical for intense MHRA regulator interactions and commercial launch, and clinic coordination, and new trial inds and/or initiation, corporate collaborations, consult/contractor interactions and patient coordination, and Nice interactions, etc.
What, do you work for ASCO or something?
Market Data 
Markets 
AI
